Citi Maintains a 'Buy' on Covidien (COV); Valuation Very Attractive
Tweet Send to a Friend
Citi maintains a 'Buy' on Covidien Ltd (NYSE: COV). Price target $46.
Citi analyst says, "COV has been ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst says, "COV has been ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
